The new treatment utilizes advanced biostimulation technology to address skin aging at a biological level rather than offering temporary cosmetic fixes. According to Dr. Ross A. Clevens of Clevens Face & Body Specialists, the procedure aligns with growing patient demand for evidence-based care that promotes healthier skin for the future. Physicians within the Premier Plastic Surgery Partners network, including Dr. Stephen Ronan and Dr. Jeffrey Spiegel, served as key opinion leaders during the clinical evaluation phase of the technology.

Onyxa Medical CEO Travis Mahan noted that the collaboration with these surgeons is intended to advance the understanding of subdermal laser tissue remodeling. The treatment is designed to integrate into existing aesthetic regimens, whether as a standalone service or in combination with surgical procedures and injectables. Participating practices have completed training on the specialized protocols, and consultations are now available for patients seeking to incorporate regenerative principles into their aesthetic care plans.